Epirubicin versus CMF as adjuvant therapy for stage I and II breast cancer: a prospective randomised study.
Colozza M, Bisagni G, Mosconi AM, Gori S, Boni C, Sabbatini R, Frassoldati A, Passalacqua R, Bian AR, Rodinò C, Rondini E, Algeri R, Di Sarra S, De Angelis V, Cocconi G, Tonato M.
Colozza M, et al. Among authors: gori s.
Eur J Cancer. 2002 Nov;38(17):2279-88. doi: 10.1016/s0959-8049(02)00452-5.
Eur J Cancer. 2002.
PMID: 12441265
Clinical Trial.